Antiviral hyped as potential Covid treatment "ineffective", finds major study

Lopinavir-ritonavir showed “no beneficial effect” in hospitalised patients not on ventilators, as per University of Oxford’s Recovery trial – the world’s largest randomised clinical trial of potential Covid treatments. “The data convincingly rule out any meaningful mortality benefit of lopinavir-ritonavir in the hospitalised Covid-19 patients,” it said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3g9rgYd
via IFTTT